【摘要】血浆置换(plasma exchange,PE)是一种用于清除循环中致病性蛋白分子或蛋白结合物质的血液净化手段,已广泛用于临床一些疾病,如自身免疫性疾病的救治中。其技术形式包括膜分离及离心分离2 种类型。PE 的技术要点包括治疗剂量及频次确定,滤器选择,治疗参数如血流量、血浆分离速度设定,置换液选择,体外循环的抗凝,治疗相关的技术并发症及临床并发症的表现及处理。本文对以上PE技术要点进行了详细阐述,以便临床更好掌握及开展这项技术。
【Abstract】Plasma exchange (PE) is a blood purification method aiming at removing circulating pathogenic proteins or protein-bound substances, which has been widely applied in treating various diseases, including autoimmune diseases. It has two technical forms: membrane separation(MPE) and centrifugal separation (CPE). The technical issues include prescription of treatment dose and frequency, choice of plasma separator, setup of treatment parameters including blood flow rate, plasma separation rate, choice of replacement fluid, anticoagulation, prevention of clinical and technical complications. In this paper, we reviewed all of the issues mentioned above in detail.
1. Kronbichler A, Brezina B, Quintana LF, et al. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review[J]. Autoimmunity Reviews. 2016;15(1):38-49.
2. Walsh M, Merkel PA, Peh CA, et al, Puéchal X, Fujimoto S, et al. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis[J]. N Engl J Med. 2020;382(7):622-31.
3. Vimal K. Derebail aRJF. ANCA-Associated Vasculitis — Refining Therapy with Plasma Exchange and Glucocorticoids[J]. New England Journal of Medicine. 2020;382(7):671-3.
4. Stevenson ME, Leung N, Winters JL, et al. What are the Newer Applications for Therapeutic Apheresis in Nephrology[J]? Seminars in Dialysis. 2016;29(5):350-3.
5. Hafer C, Golla P, Gericke M, et al, et al. Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study[J]. International Urology and Nephrology. 2015;48(1):133-8.
6. Ritzenthaler T, Beraud M, Gobert F, et al. Influence of vascular access devices upon efficiency of therapeutic plasma exchange[J]. Journal of Clinical Apheresis. 2019;34(1):33-8.
7. Ahmed S, Kaplan A. Therapeutic Plasma Exchange Using Membrane Plasma Separation[J]. Clinical Journal of the American Society of Nephrology. 2020;15(9):1364-70.
8. Feehally J, Tonelli M, Johnson RJ. Comphrehensive clinical nephrology[M]. 6th ed. Elsevier; 2019. 1132-1140.
9. Gashti CN. Membrane-based Therapeutic Plasma Exchange: A New Frontier for Nephrologists[J]. Seminars in Dialysis. 2016;29(5):382-90.
10. Fernández Sarmiento J, Varela MA, et al. Frequency of hemorrhagic complications in plasmapheresis without extracorporeal circuit anticoagulation, in children[J]. Transfusion and Apheresis Science. 2016;55(1):136-40.
11. Irani MS, Toushan M, Zhang L, et al. Risk of hypotensive reactions is increased when using partial saline replacement for therapeutic plasma exchange[J]. Journal of Clinical Apheresis. 2019;34(5):524-7.
12. Fan R, Wu B, Kong L, et al. Severe Hemolysis in a Patient With Erythrocytosis During Coupled Plasma Filtration Adsorption Therapy Was Prevented by Changing From Membrane-Based Technique to a Centrifuge-Based One[J]. Am J Ther. 2016;23(4):e1124-7.
13. Kaplan AA. Therapeutic plasma exchange: a technical and operational review[J]. J Clin Apher. 2013;28(1):3-10.
14. Mokrzycki MH, Balogun RA. Therapeutic apheresis: a review of complications and recommendations for prevention and management[J]. J Clin Apher. 2011;26(5):243-8.
15. Lee T, Yang JJ, Kim S, et al. Risk management strategy for reducing therapeutic plasma exchange-related allergic reactions[J]. Allergy. 2020;75(4):962-5.
16. Zhao Y, Garrity D, Graves M, et al. Optimization of infusional calcium gluconate for prevention of hypocalcemic reactions during therapeutic plasma exchange[J]. Journal of Clinical Apheresis. 2019;34(6):656-60.
17. Hodulik KL, Root AG, Ledbetter LS, et al. Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review[J]. Transfusion. 2019;59(5):1870-9.
18. Mahmoud SH, Buhler J, Chu E, et al. Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange[J]. Neurocritical Care. 2020.